Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:38 PM
Ignite Modification Date:
2025-12-24 @ 1:38 PM
NCT ID:
NCT00474695
Eligibility Criteria:
Inclusion Criteria:
* Treatment naive AMD patients;
* At least 50 years of age;
* Visual acuity between 20/40 and 20/320
Exclusion Criteria:
* Pregnancy;
* Prior enrollment in a ranibizumab clinical trial;
* Previous therapy in either eye for AMD;
* Concurrent eye disease that could compromise visual acuity
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
50 Years
Study:
NCT00474695
Study Brief:
Protocol Section:
NCT00474695